Use of MTKI 1 for treating or preventing bone cancer

Details for Australian Patent Application No. 2007310845 (hide)

Owner Janssen Pharmaceutica NV

Inventors Perera, Timothy Pietro Suren; Janicot, Michel Marie Francois; Meert, Theo Frans; Freyne, Eddy Jean Edgard

Agent Shelston IP

Pub. Number AU-A-2007310845

PCT Pub. Number WO2008/049904

Priority 60/976,188 28.09.07 US; 06123060.3 27.10.06 EP; 60/863,167 27.10.06 US

Filing date 25 October 2007

Wipo publication date 2 May 2008

International Classifications

A61K 31/529 (2006.01) - forming part of bridged ring systems

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/049904 Priority application(s): WO2008/049904

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007310859-Radially expanding a tubular element

2007310843-Macrocyclic quinazoline derivatives as VEGFR3 inhibitors